Michael Gelband’s Stantec STN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53M Buy
36,710
+29,823
+433% +$2.4M 0.02% 737
2026
Q1
$595K Sell
6,887
-613
-8% -$57.7K ﹤0.01% 1144
2025
Q4
$708K Buy
+7,500
New +$772K 0.01% 1094
2025
Q3
Sell
-2,441
Closed -$265K 1998
2025
Q2
$265K Buy
+2,441
New +$235K ﹤0.01% 1265
2025
Q1
Sell
-4,000
Closed -$314K 1967
2024
Q4
$314K Sell
4,000
-12,614
-76% -$1.05M ﹤0.01% 1268
2024
Q3
$1.34M Buy
+16,614
New +$1.37M 0.01% 882
2024
Q2
Sell
-14,993
Closed -$1.25M 1961
2024
Q1
$1.25M Buy
+14,993
New +$1.23M 0.01% 871
2021
Q2
Sell
-6,034
Closed -$258K 2783
2021
Q1
$258K Buy
+6,034
New +$232K ﹤0.01% 1752

Other funds holding STN

Michael Gelband's STN Position: Q2 2026 in Review

Michael Gelband increased its Stantec (STN) stake by 433% in Q2 2026, buying an estimated $2.4M and bringing the position to 36,710 shares worth $2.53M. The position accounts for 0.02% of the portfolio, ranked #737.

Michael Gelband first reported a position in STN in Q1 2021 and has held it in 8 quarters since. 289 funds tracked by Wall St. Rank hold STN as of Q2 2026.

  • Michael Gelband held 36,710 shares of Stantec worth $2.53M as of Q2 2026.
  • Michael Gelband bought 29,823 Stantec shares in Q2 2026, an estimated $2.4M.
  • Stantec made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #737 holding.
  • Michael Gelband first reported a position in Stantec in Q1 2021 and has held it in 8 quarters since.
  • 289 funds tracked by Wall St. Rank held Stantec as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.